Skip to content
Investors

"One of the Core Values we live by at Danaher is We Compete for Shareholders, and we believe we are uniquely positioned to deliver meaningful, long-term shareholder value for many years to come."

RAINER M. BLAIR
President and CEO

NYSEDHR

Investor Relations

Danaher’s proven business system drives performance. We are proud to be a Fortune 200 company, and our stock has outperformed the S&P 500 index by more than 2,000% over the past 25 years.

Press Releases
Jul 11, 2024

Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures...

Jun 24, 2024

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesday, July 23, 2024 beginning at 8:00 a.m. ET and lasting...

Jun 19, 2024

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis...

View all news

Company Overview

Danaher Overview Presentation

Download presentation

Sustainability

2023 Sustainability Report

Download report

Danaher Business System

The Danaher Business System (DBS) is our system of continuous improvement and the culture that makes it work.

See the DBS difference

Contact Investor Relations

John Bedford
Vice President
Investor Relations

Travis Taylor
Manager
Investor Relations

IR Team Contact Info
Email: investor.relations@danaher.com
Tel: +1 202 828 0850

Contact us

Subscribe to Investor Updates

Sign up to receive updates on the latest investor events, reports, news and more from our IR team.

Subscribe